Jon Grant, JD, MD, MPH

Education & Training

• B.A., 1986, University of Michigan
• M.A., 1987, University of Chicago
• J.D., 1992, Cornell University
• M.D., 1999, Brown University
• M.P.H., 1999, Harvard University
• Residency, 1999-2003, Department of Psychiatry, University of Minnesota
• Board Certified, American Board of Psychiatry and Neurology (Adult, General)
• Board Certified, American Board of Addiction Medicine

Clinical Interests

• Addictive, impulsive and compulsive disorders
• Sexual disorders
• Neuropsychopharmacology

Research Interests

• Therapeutic interventions for impulsive-compulsive disorders
• Neurocognitive correlates of impulsive-compulsive behavior
• Neural basis of cognitive, emotional and behavioral dysfunction

Teaching

• Addiction lectures, Psychiatry residency program, 2012-2013

Society Memberships

• Fellow, American Psychiatric Association
• Member, Society of Biological Psychiatry
• Member, International Society for Research on Impulsivity and Impulse Control Disorders
• Member, International College of Obsessive Compulsive Spectrum Disorders
• Fellow, American Psychopathological Association
• Member, American College of Psychiatrists
• Member, American College of Neuropsychopharmacology

Selected Publications

• Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder: an under-recognized and under-treated disorder.  Am J Psychiatry (in press)
• Hodgins DC, Stea JN, Grant JE. 2011. Gambling disorders. The Lancet 378(9806):1874-84.
• Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. 2010. Nalmefene in the treatment pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 197:330-331
• Grant JE, Oldaug BL, Kim SW. 2009. A double-blind, placebo-controlled trial of a glutamate modulating agent, N-acetyl cysteine, in the treatment of trichotillomania. Arch Gen Psychiatry 66(7): 756-763
• Grant JE, Kim SW, Odlaug BL.2009. A double-blind, placebo-controlled trial of the opioid antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 65(7):600-606
• Grant JE, Donahue CJ, Odlaug BL, Kim SW, Miller MJ, Petry NM. 2009. Imaginal desensitization plus motivational interviewing in the treatment of pathological gambling: a randomized controlled trial. Br J Psychiatry 195:266-267
• Grant JE, Kim SW, Odlaug BL. 2007. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 62(6):652-657
• Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. 2006. A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303-312
• Grant JE, Levine L, Kim D, Potenza MN. 2005. Impulse control disorders in adult psychiatric       inpatients. Am J Psychiatry 162:2184-2188

Selected Conferences & Presentations

• Keynote. National Association for Gambling Studies of Australia. Cognition in gambling disorders. Melbourne, Australia. 2011
• Keynote. National Gambling Association of Korea. Clinical treatment of pathological gambling. Seoul, South Korea. 2011
• Keynote. Finnish Society of Addiction Medicine. Pathological gambling: neurobiology and pharmacological treatment. Turku, Finland. 2009
• Keynote. Asian Pacific Problem Gambling and Addictions Conference.  Pharmacological management of pathological gambling. Hong Kong. 2008
• ABC Primetime. Kleptomania. 2005
• The Jane Pauley Show, NBC. Pathological gambling in women. 2005
• CBS Early Show. Kleptomania. 2004
• ESPN.  Pete Rose on Trial. 2003

Other Activities

• Board Member, South African Responsible Gambling Foundation
• International Advisory Panel for Addictions – Minister for Health - Singapore
• Advisory Chair, Scientific Advisory Board, Trichotillomania Learning Center